CRG and Fundació ACE to collaborate in genomics

May 25, 2012

LCGC Europe eNews

LCGC Europe eNews-05-25-2012, Volume 0, Issue 0

The Centre for Genomic Regulation (CRG) (Barcelona, Spain) and the Fundació ACE - Barcelona Alzheimer Treatment & Research Centre (Barcelona, Spain) have signed an agreement to collaborate on scientific projects related to neurodegenerative diseases.

The Centre for Genomic Regulation (CRG) (Barcelona, Spain) and the Fundació ACE - Barcelona Alzheimer Treatment & Research Centre (Barcelona, Spain) have signed an agreement to collaborate on scientific projects related to neurodegenerative diseases.

The agreement, which will initially last for two years, aims to encourage collaboration between the centres. They will work together in the area of genomics as well as functional studies of cases of neurodegenerative diseases.

Dr Mercè Boada, medical director of the ACE Foundation, said, “The start of this collaboration with the CRG represents a huge step forward for our institution and strengthens the basic research of the ACE Foundation. The agreement will allow us to intensify our research on the genetic causes of dementia and complements the collaborations that have been initiated with the international metaconsortia CHARGE and IGAP.”

Xavier Estivill, coordinator of the CRG Genes and Disease programme, commented, “If we study neurodegenerative diseases from a genomic perspective we will probably discover fundamental explanations about the causes. As we age later in life than we did previously, neurodegenerative diseases are becoming more common. Understanding the biological basis of these ailments will help us to delay their appearance, improve diagnosis, and develop new treatments.”

For more information please visit ref="http://www.crg.es">www.crg.es

Related Content:

News